Evaluation of the Hepatitis C Care Cascade in the Country of Georgia: Monitoring Progress Towards Elimination
IVHEM 2019. November 22-23, 2019, Amsterdam EVALUATION OF THE HEPATITIS C CARE CASCADE IN THE COUNTRY OF GEORGIA: MONITORING PROGRESS TOWARDS ELIMINATION Tengiz Tsertsvadze,1,2 Amiran Gamkrelidze,3 Nikoloz Chkhartishvili,1 Akaki Abutidze,1 Lali Sharvadze,2,4 Maia Butsashvili,5 David Metreveli,6 Lia Gvinjilia,7 Shaun Shadaker,8 Muazzam Nasrullah,8 Tamar Gabunia, 9 Ekaterine Adamia,9 Stefan Zeuzem,10 Nezam Afdhal,11 Sanjeev Arora,12 Karla Thornton,12 Francisco Averhoff8 1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia; 2Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia; 3National Center for Disease Control and Public Health, Tbilisi, Georgia; 4Hepatology clinic HEPA, Tbilisi, Georgia; 5Health Research Union, Tbilisi, Georgia; 6Medical Center Mrcheveli, Tbilisi, Georgia; 7CDC Foundation, Tbilisi, Georgia; 8Centers for Disease Control and Prevention, Division of Viral Hepatitis National Center for HIV, Hepatitis, STD&TB Prevention, Atlanta, USA; 9Ministry of IDPs, Labour, Health and Social Affairs of Georgia, Tbilisi, Georgia; 10Goethe University Hospital, Frankfurt, Germany; 11Beth Israel Deaconess Medical Center Liver Center, Boston, USA; 12University of New Mexico, Albuquerque, USA Infectious Diseases, AIDS and Clinical Immunology Research Center Disclosure No relevant financial relationship exists Infectious Diseases, AIDS and Clinical Immunology Research Center 12 COUNTRIES WORLDWIDE ON TRACK TO ELIMINATE HEPATITIS C INFECTION BY 2030 Georgia’s HCV elimination program builds on delivering
[Show full text]